Status:
UNKNOWN
Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Conditions:
Chronic Obstructive Pulmonary Disease
Alpha 1-Antitrypsin Deficiency
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Pulmonary rehabilitation (PR) including exercise training is highly effective by improving health-related quality of life, exercise capacity and symptoms in patients with chronic obstructive pulmonary...
Eligibility Criteria
Inclusion
- COPD patients with A1ATD (genotype PiZZ)
- COPD patients without A1ATD (genotype PiMM)
- Global initiative for chronic obstructive lung disease (GOLD) stage III-IV
- Medical Treatment according to recent A1ATD guidelines
Exclusion
- General exclusion criteria for physical Training such as acute coronary Syndrome, acute myo- or pericarditis, acute lung embolism, acute heart failure, orthopedic comorbidities which prevent patients from participating in exercise Training program.
- No written informed consent
- Non-compliance
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03802357
Start Date
January 10 2019
End Date
December 31 2021
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, Germany, 83471